Literature DB >> 24413320

Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes.

L Wang1, S I Swierczek2, J Drummond1, K Hickman2, S J Kim2, K Walker1, H Doddapaneni1, D M Muzny1, R A Gibbs1, D A Wheeler1, J T Prchal2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24413320      PMCID： PMC4532385          DOI： 10.1038/leu.2014.7

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients.

Authors:  T L Lasho; C M Finke; C A Hanson; T Jimma; R A Knudson; R P Ketterling; A Pardanani; A Tefferi
Journal:  Leukemia       Date:  2011-11-08       Impact factor: 11.528

2.  Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient.

Authors:  Nisha Rao; Carolyn M Butcher; Ian D Lewis; David M Ross; Junia V Melo; Hamish S Scott; Peter G Bardy; Richard J D'Andrea
Journal:  Br J Haematol       Date:  2011-08-22       Impact factor: 6.998

3.  Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.

Authors:  L Side; B Taylor; M Cayouette; E Conner; P Thompson; M Luce; K Shannon
Journal:  N Engl J Med       Date:  1997-06-12       Impact factor: 91.245

4.  Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.

Authors:  Robert Kralovics; Yongli Guan; Josef T Prchal
Journal:  Exp Hematol       Date:  2002-03       Impact factor: 3.084

5.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

6.  Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis.

Authors:  J T Prchal; Y L Guan; J F Prchal; F Barany
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

7.  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.

Authors:  Catriona H M Jamieson; Jason Gotlib; Jeffrey A Durocher; Mark P Chao; M Rajan Mariappan; Marla Lay; Carol Jones; James L Zehnder; Stan L Lilleberg; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

8.  Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism.

Authors:  J T Prchal; J F Prchal; M Belickova; S Chen; Y Guan; G L Gartland; M D Cooper
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

Authors:  E Papaemmanuil; M Cazzola; J Boultwood; L Malcovati; P Vyas; D Bowen; A Pellagatti; J S Wainscoat; E Hellstrom-Lindberg; C Gambacorti-Passerini; A L Godfrey; I Rapado; A Cvejic; R Rance; C McGee; P Ellis; L J Mudie; P J Stephens; S McLaren; C E Massie; P S Tarpey; I Varela; S Nik-Zainal; H R Davies; A Shlien; D Jones; K Raine; J Hinton; A P Butler; J W Teague; E J Baxter; J Score; A Galli; M G Della Porta; E Travaglino; M Groves; S Tauro; N C Munshi; K C Anderson; A El-Naggar; A Fischer; V Mustonen; A J Warren; N C P Cross; A R Green; P A Futreal; M R Stratton; P J Campbell
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

Review 10.  From human genome to cancer genome: the first decade.

Authors:  David A Wheeler; Linghua Wang
Journal:  Genome Res       Date:  2013-07       Impact factor: 9.043
View more
  13 in total

Review 1.  Novel insights into the biology and treatment of chronic myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Tiziano Barbui; Omar Abdel-Wahab; Robert Kralovics; Catriona Jamieson; Hans-Michael Kvasnicka; Ann Mullaly; Raajit Rampal; Ruben Mesa; Jean-Jacques Kiladjian; Michael Deininger; Josef Prchal; Rüdiger Hehlmann; Giuseppe Saglio; Richard A Van Etten
Journal:  Leuk Lymphoma       Date:  2014-11-19

2.  Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera.

Authors:  Lucie Lanikova; Olga Babosova; Sabina Swierczek; Linghua Wang; David A Wheeler; Vladimir Divoky; Vladimir Korinek; Josef T Prchal
Journal:  Blood       Date:  2016-09-19       Impact factor: 22.113

Review 3.  Polycythemia Vera.

Authors:  Jerry L Spivak
Journal:  Curr Treat Options Oncol       Date:  2018-03-07

Review 4.  Familial MPN Predisposition.

Authors:  Tsewang Tashi; Sabina Swierczek; Josef T Prchal
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 5.  Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations.

Authors:  Bing Li; John O Mascarenhas; Raajit K Rampal
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 6.  Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.

Authors:  Brady L Stein; Stephen T Oh; Dmitriy Berenzon; Gabriela S Hobbs; Marina Kremyanskaya; Raajit K Rampal; Camille N Abboud; Kenneth Adler; Mark L Heaney; Elias J Jabbour; Rami S Komrokji; Alison R Moliterno; Ellen K Ritchie; Lawrence Rice; John Mascarenhas; Ronald Hoffman
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

7.  Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.

Authors:  E K Engle; D A C Fisher; C A Miller; M D McLellan; R S Fulton; D M Moore; R K Wilson; T J Ley; S T Oh
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

8.  Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.

Authors:  E Togasaki; J Takeda; K Yoshida; Y Shiozawa; M Takeuchi; M Oshima; A Saraya; A Iwama; K Yokote; E Sakaida; C Hirase; A Takeshita; K Imai; H Okumura; Y Morishita; N Usui; N Takahashi; S Fujisawa; Y Shiraishi; K Chiba; H Tanaka; H Kiyoi; K Ohnishi; S Ohtake; N Asou; Y Kobayashi; Y Miyazaki; S Miyano; S Ogawa; I Matsumura; C Nakaseko; T Naoe
Journal:  Blood Cancer J       Date:  2017-04-28       Impact factor: 11.037

9.  Whole-Exome Sequencing of ETV6/RUNX1 in Four Childhood Acute Lymphoblastic Leukaemia Cases

Authors:  Zubaidah Zakaria; Norodiyah Othman; Azli Ismail; Nor Rizan Kamaluddin; Ezalia Esa; Eni Juraida Abdul Rahman; Yuslina Mat Yusoff; Fazlin Mohd Fauzi; Ten Sew Keoh
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

Review 10.  Clonal hematopoiesis and its emerging effects on cellular therapies.

Authors:  Malte von Bonin; Helena Klara Jambor; Raphael Teipel; Friedrich Stölzel; Christian Thiede; Frederik Damm; Frank Kroschinsky; Johannes Schetelig; Triantafyllos Chavakis; Martin Bornhäuser
Journal:  Leukemia       Date:  2021-07-02       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.